机构

• 上海药物研究所 [13]
• 合肥物质科学研究院 [9]
• 自动化研究所 [2]
• 心理研究所 [1]
• 海洋研究所 [1]
• 生态环境研究中心 [1]
• 更多

采集方式

• OAI收割 [27]

内容类型

• 期刊论文 [27]

发表日期

• 2022 [27]

学科主题

筛选

浏览/检索结果: 共27条，第1-10条 帮助 限定条件 发表日期：2022     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study 期刊论文  OAI收割 EBIOMEDICINE, 2022, 卷号: 86, 页码: 13 作者:  She, Yunlang;  He, Bingxi;  Wang, Fang;  Zhong, Yifan;  Wang, Tingting   |  收藏  |  浏览/下载：20/0  |  提交时间：2023/02/22 Deep learning  Neoadjuvant chemoimmunotherapy  Major pathological response  Non-small cell lung cancer   Fucoidan, as an immunostimulator promotes M1 macrophage differentiation and enhances the chemotherapeutic sensitivity of capecitabine in colon cancer 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 卷号: 222, 页码: 562-572 作者:  Deng, Zhenzhen;  Wu, Ning;  Suo, Qishan;  Wang, Jing;  Yue, Yang   |  收藏  |  浏览/下载：38/0  |  提交时间：2023/01/04 Capecitabine  Tumor microenvironment  Macrophages  TLR4  Fucoidan   In-situ clickable prodrug nanoplatform locally activates T lymphocytes to potentiate cancer immunotherapy 期刊论文  OAI收割 NANO TODAY, 2022, 卷号: 47, 页码: 11 作者:  Hou, Bo;  Ye, Jiayi;  Li, Junhao;  Xu, Zhiai;  Yu, Haijun   |  收藏  |  浏览/下载：29/0  |  提交时间：2023/04/10 Immune-excluded tumor  Extracellular matrix  In-situ click reaction  Prodrug nanoparticles  Immune resistance   ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression 期刊论文  OAI收割 NATURE COMMUNICATIONS, 2022, 卷号: 13, 期号: 1, 页码: 20 作者:  Li, Ni;  Liu, Qiuli;  Han, Ying;  Pei, Siyu;  Cheng, Bisheng   |  收藏  |  浏览/下载：20/0  |  提交时间：2023/04/10 Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文  OAI收割 BMC Medicine, 2022, 卷号: 20, 期号: 1 作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun   |  收藏  |  浏览/下载：19/0  |  提交时间：2022/11/21 Tucidinostat  Tumor microenvironment  PD-L1  CCL5  Solid tumor   Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12 作者:  Zhou, Shuguang;  Zhang, Weiyu;  Cao, Wujun;  Jin, Qinqin;  Jiang, Xiya   |  收藏  |  浏览/下载：26/0  |  提交时间：2022/12/23 cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC)  long noncoding RNA (lncRNA)  autophagy-related genes (ARGs)  autophagy-related lncRNAs (ARLs)  prognostic signature  immune infiltration   Metabolic-related gene pairs signature analysis identifies ABCA1 expression levels on tumor-associated macrophages as a prognostic biomarker in primary IDHWT glioblastoma 期刊论文  OAI收割 FRONTIERS IN IMMUNOLOGY, 2022, 卷号: 13 作者:  Wang, Shiqun;  Li, Lu;  Zuo, Shuguang;  Kong, Lingkai;  Wei, Jiwu   |  收藏  |  浏览/下载：22/0  |  提交时间：2022/12/22 primary glioblastoma  wild-type isocitrate dehydrogenase  metabolic-related gene pairs  prognosis  tumor-associated macrophages  ABCA1   Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12 作者:  Zhang, Jiawei;  Wu, Yinan;  Mu, Jiayi;  Xin, Dijia;  Wang, Luyao   |  收藏  |  浏览/下载：20/0  |  提交时间：2022/12/22 colorectal cancer  glycosyltransferase  lncRNAs  risk model  overall survival   Identification of hexosamine biosynthesis pathway as a novel prognostic signature and its correlation with immune infiltration in bladder cancer 期刊论文  OAI收割 FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 卷号: 9, 页码: 13 作者:     |  收藏  |  浏览/下载：26/0  |  提交时间：2022/12/13 hexosamine biosynthesis pathway  bladder cancer  prognosis  immune infiltration  risk score   The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study 期刊论文  OAI收割 CANCERS, 2022, 卷号: 14 作者:  Xie, Mingying;  Li, Na;  Xu, Xiaoling;  Xu, Yanjun;  Li, Hui   |  收藏  |  浏览/下载：21/0  |  提交时间：2022/12/22 liver metastasis  non-small cell lung cancer  PD-L1  PD-1  PD-L1 inhibitor  CD8+T cell